KRKA: 2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto

2023-07-20 08:16

publikacja
2023-07-20 08:16

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
H1_2023_Unaudited_Interim_Report_of_the_Krka_Group_and_Krka_Novo_mesto.pdf (REPORT)
Press_Release.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		26	/	2023
Date of issue:	2023-07-20
Short name of the issuer
KRKA
Subject
2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 136 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the 2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto. The report will be published on the Company's website (www.krka.biz) from 20 July 2023 onwards, for a period of at least 10 years.
Annexes
File			Description
H1 2023 Unaudited Interim Report of the Krka Group and Krka Novo mesto.pdfH1 2023 Unaudited Interim Report of the Krka Group and Krka Novo mesto.pdf			2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto
Press Release.pdfPress Release.pdf			Press Release

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2023-07-20	Jože Colarič	President of the Management Board and CEO

Ważne linki